Intelliseq

Wilczynskiego 19
Krakow,  31-358

Poland
https://intelliseq.com/
  • Booth: 546

Intelliseq’s mission is to make genome-based medicine practical by providing solutions for genetic data analysis. We translate raw NGS data into complete reports with clinical insights that support patients and healthy individuals in a variety of decisions according to diagnostics, treatment, and prevention (genetic disorders, somatic cancer, PGx, and polygenic risk scores). Recently we have launched IntelliseqFlow, an automated and cost-effective web-based platform for NGS data analysis.


 Press Releases

  • We are thrilled to announce the release of IntelliseqFlow, an automated and cost-effective web-based platform for NGS data analysis!

    IntelliseqFlow translates raw DNA data into complete reports with clinical insights (from fastq to pdf report).

    Our mission was to create an intuitive and user-friendly application so that it could be operated not only by bioinformaticians.

    It works as SaaS with no upfront cost and it can be easily integrable with LIMS or EHR. Thanks to the use of cloud technology it is fully automatic and scalable.

    The workflows available in the application are dedicated to different fields of genome-based medicine, including genetic disorders, somatic cancer, PGx, and polygenic risk scores for health- and wellness-related traits.

    Our platform is fully secure and regulatory compliant, Intelliseq is ISO 13485 certified (the certificate was granted for the “design, manufacture, and sale of a medical device in the form of software supporting genetic diagnostics”) and HIPPA compliant.

    Go to FREE TRIAL or learn more about the platform https://intelliseq.com/

  • We invite you to watch the video presenting the main advantages of the IntelliseqFlow platform: https://www.youtube.com/watch?v=-mSmHxd8o6U

    IntelliseqFlow - software as a service platform for NGS data analysis with no upfront cost. IntelliseqFlow translates your raw DNA data into complete reports with clinical insights. Our drop-in solution fits all NGS analysis approaches: from a single gene to a whole genome, for genetic diseases, hereditary and somatic cancer, carrier screening, pharmacogenetics, and polygenic risk scores for wellness- and health-related traits. It enables labs to access genome-based diagnostics and precision medicine.


 Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes